Ugma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.37 M
- Company Age 43 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 M
- Satisfied Charges ₹ 5.25 M
- Revenue Growth %
- Ebitda
- Net Worth -0.69%
- Total Assets -4.07%
About Ugma Laboratories
Ugma Laboratories Private Limited (ULPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 1981 and has a history of 43 years and two months. Its registered office is in Uttar Pradesh, Uttar Pradesh.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.37 M.
The company currently has active open charges totaling ₹1.70 M. The company has closed loans amounting to ₹5.25 M, as per Ministry of Corporate Affairs (MCA) records.
Madhu Bhargava, Shivani Bvhargava, Swatantra Bhargava, and One other member serve as directors at the Company.
Company Details
- Location Uttar Pradesh, Uttar Pradesh
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24236UP1981PTC005476
-
Company No.
005476
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 1981
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Ugma Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhu Bhargava
|
Director | 01-Jan-2003 | Current |
|
Shivani Bvhargava
|
Director | 18-Nov-2017 | Current |
|
Swatantra Bhargava
|
Director | 03-Jun-2021 | Current |
|
Sandeep Bhargava
|
Director | 03-Jun-2021 | Current |
Financial Performance of Ugma Laboratories.
Ugma Laboratories Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ugma Laboratories?
In 2017, Ugma Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ankur Pharmaceuticals Private LimitedMadhu Bhargava, Shivani Bvhargava and 1 more are mutual person
Charges (Loans)
₹1.70 M
₹5.25 M
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.17 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Aug 2000 | Bank Of Baroda | ₹1.40 M | Open |
| 29 Apr 2000 | Bank Of Baroda | ₹0.20 M | Open |
| 11 Apr 1984 | Bank Of Baroda | ₹0.10 M | Open |
| 23 Apr 2002 | State Bank Of India | ₹4.00 M | Satisfied |
| 19 Jan 1995 | Bank Of Baroda | ₹1.25 M | Satisfied |
How Many Employees Work at Ugma Laboratories?
Unlock and access historical data on people associated with Ugma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ugma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ugma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
